CSIMarket Company Name, Ticker, Customers, else..


Surrozen Inc   (NASDAQ: SRZN)
Other Ticker:  
 

Surrozen Inc

SRZN's Fundamental analysis



Looking into Surrozen Inc growth rates, revenue grew in the second quarter of 2025 from the same quarter a year ago. Ranking at No. 2645

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 1.92 %

Surrozen Inc realized net income compared to net loss a year ago in second quarter of 2025

• More on SRZN's Growth


Surrozen Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 3.32 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 13.85.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.36.


• More on SRZN's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 315,525
 Net Income/Employee (TTM) $ -865,875
 Receivable Turnover (TTM) 2.7
 Tangible Book Value (Per Share $) 5.52

Surrozen Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 3.32 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 13.85.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.36.

Surrozen Inc Price to Book Ratio is at 3.71 lower than Industry Avg. of 1638.9. and higher than S&P 500 Avg. of 0.02

• More on SRZN's Valuation

•  Market Capitalization (Millions $) 175
•  Shares Outstanding (Millions) 9
•  Employees 40
•  Revenues (TTM) (Millions $) 13
•  Net Income (TTM) (Millions $) -35
•  Cash Flow (TTM) (Millions $) 53
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 315,525
•  Net Income/Employee(TTM) $ -865,875
•  Receivable Turnover Ratio (TTM) 2.7
•  Tangible Book Value (Per Share $) 5.52

•  Market Capitalization (Millions $) 175
•  Shares Outstanding (Millions) 9
•  Employees 40
•  Revenues (TTM) (Millions $) 13
•  Net Income (TTM) (Millions $) -35
•  Cash Flow (TTM) (Millions $) 53
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 6.1
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 1.18
•  Asset Turnover Ratio (TTM) 0.17
•  Inventory Turnover Ratio (TTM) -





Surrozen Inc net profit margin of 2218.51 % is currently ranking no. 2 in Biotechnology & Pharmaceuticals industry, ranking no. 6 in Healthcare sector and number 16 in S&P 500.

• More on SRZN's Key Ratios





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.